1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
#$%^&*AU2012203815A120120719.pdf#####C:NRPonrlDCC\NLB\44234X5 I DOC-2W6>2fl12 ABSTRACT The present invention provides a compound of formula (1): wherein the variants R1, R2, R3, R4, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP. R7 (l) I RI R6 R4 N R2 R3